pentobarbital decreases effects of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Closely. Coadministration of CYP3A4 inducers may well minimize sufentanil concentrations and efficacy, possibly precipitating withdrawal syndrome in individuals that have designed physical dependence to sufentanil